Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)

NARecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

June 5, 2026

Study Completion Date

June 5, 2026

Conditions
AdultGynecological Tumors
Interventions
BIOLOGICAL

Autologous tumor infiltrating lymphocyte injection(GT201)

GT201 treatment for advanced gynecological tumors (advanced cervical cancer)

Trial Locations (1)

200000

RECRUITING

Shanghai Tenth People's Hospital, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Grit Biotechnology

INDUSTRY